EMA: IN JANUARY 2022, PRAC CONCLUDED THAT TRANSVERSE MYELITIS SHOULD BE ADDED TO THE PRODUCT INFORMATION AS A SIDE EFFECT OF ASTRAZENECA VACCINE
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
12,156 GBX | -0.12% | +7.88% | 236B | ||
- Stock Market
- Stock Market News in real time
- Economy
- Ema: In January 2022, Prac Concluded That Transverse Myelitis Should Be Added To The Product Information As A Side Effect Of Astrazeneca Vaccine